文献速递心血管US

我们是否应检测舒张功能障碍?如何检测与检测频率如何?

Should We Test for Diastolic Dysfunction? How and How Often?
PubMed 文献 · JACC Cardiovasc Imaging · 2019-06-12

本文综述舒张功能评估在心力衰竭诊断、预后判断和治疗指导中的价值。单个超声心动图参数与左室充盈压相关性弱,多参数联合可提高检测准确性;血清利钠肽升高是心衰关键诊断标准;现有证据不足以推荐系列超声或利钠肽监测指导治疗;植入式压力传感器直接测压是唯一被证实可降低心衰住院率的舒张功能评估方法。

要点

  • 单个超声参数与左室充盈压相关性弱,多参数联合可提高检测准确性。
  • 血清利钠肽水平与心室充盈压相关,升高时是心衰的关键诊断标准。
  • 现有证据不足以推荐系列超声或利钠肽监测来评估充盈压变化或指导心衰治疗。

核心结论

  • 现有证据不足以推荐系列超声心动图检查或利钠肽水平测定来评估充盈压变化或指导心衰治疗。
  • 下腔静脉大小和动态变化有潜力识别急性失代偿性心衰发作期间减压不充分,但尚未证明能改善心衰结局。
  • 使用植入式压力传感器直接测量左室充盈压是迄今唯一被证明能降低心衰住院率的「舒张功能评估」方法。

研究设计与样本

  • 综述类文章,检索范围与纳入文献原文未报告。

诊断标准与关键数值

  • 单个超声心动图参数与直接测得的左室充盈压相关性弱,多参数联合可提高检测左室充盈压升高的准确性。
  • 血清利钠肽水平与心室充盈压相关,升高时是心衰的关键诊断标准。
  • 下腔静脉大小和动态变化有潜力识别急性失代偿性心衰发作期间减压不充分,但尚未证明能改善心衰结局。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Symptoms of heart failure (HF) are due in large part to elevation of left and/or right ventricular filling pressures. Although abnormal diastolic function is difficult to define, it contributes to the elevation of filling pressures. Tests that characterize aspects of diastolic function or structural changes associated with diastolic dysfunction, may help in establishing a diagnosis of HF, assessing prognosis, and guiding treatments. Individual echocardiographic parameters correlate weakly with LV (LV) filling pressures measured directly. However, a combination of multiple parameters improves accuracy for detection of elevated filling pressures. Serum natriuretic peptide levels are related to ventricular filling pressures and, when elevated, are a key diagnostic criterion for HF. Currently available evidence is not adequate to recommend serial echocardiographic studies or natriuretic peptide level measurements to assess changes in filling pressures or to guide HF therapy. Measurements of inferior vena cava size and dynamics have potential for identifying inadequate decongestion during episodes of acute decompensated HF but have not yet demonstrated utility in improving HF outcomes. Direct measurement of LV filling pressures using implanted pressure sensors is the only "diastolic assessment" thus far that has proven efficacy in reducing HF hospitalization rates.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Litwin SE, Zile MR. Should We Test for Diastolic Dysfunction? How and How Often? JACC Cardiovasc Imaging. 2019. PMID: 31202743. doi:10.1016/j.jcmg.2019.02.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。